Lucio phenomenon is treated with –
**Core Concept**
The Lucio phenomenon is a rare but severe complication of leprosy, characterized by necrotizing vasculitis and endothelial damage, leading to skin and systemic manifestations. This condition is caused by an intense immune response to Mycobacterium leprae, resulting in the release of pro-inflammatory cytokines and the activation of immune cells.
**Why the Correct Answer is Right**
The treatment of the Lucio phenomenon involves addressing the underlying immune dysregulation and inflammation. Corticosteroids, such as prednisolone, are administered to suppress the immune response and reduce inflammation. This is achieved by inhibiting the production of pro-inflammatory cytokines and reducing the activation of immune cells. Additionally, corticosteroids help to prevent further tissue damage and promote healing.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because antibiotics, such as rifampicin and clofazimine, are used to treat leprosy, but they do not address the underlying immune dysregulation and inflammation associated with the Lucio phenomenon.
**Option B:** This option is incorrect because antiviral medications are not indicated in the treatment of the Lucio phenomenon, as it is not caused by a viral infection.
**Option C:** This option is incorrect because immunosuppressive medications, such as cyclophosphamide, may worsen the condition by further suppressing the immune system.
**Clinical Pearl / High-Yield Fact**
The Lucio phenomenon is a medical emergency that requires prompt recognition and treatment to prevent severe complications and mortality. Early initiation of corticosteroid therapy can significantly improve outcomes and reduce the risk of long-term sequelae.
**Correct Answer: A. Prednisolone.**